D035683
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| CIRCULATING MICRO-RNA (miRNA) AND AR-V7 MUTATIONAL STATUS IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (CRPC): PRIMERA+ STUDY (PROSTATE CANCER INNOVATING MARKERS OF EXPECTED RESPONSE TO AGONIST LHRH+ ANDROGEN RECEPTOR INHIBITION (NCT04188275) | Azienda Ospedaliero-Universitaria Careggi | 2018-12-01 |
Track D035683 automatically
Every clearance here is in the API, with alerts when new ones post.